{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:39:31Z","timestamp":1787603971548,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Lifestyle modifications aimed at weight loss have been introduced as a cornerstone of nonalcoholic fatty liver disease (NAFLD) management. However, very few patients follow the doctor's prescription to change their lifestyle to achieve weight loss in the real world. The purpose of this study was to use the Health Action Process Approach (HAPA) model to examine the factors that affect adherence to lifestyle prescriptions among patients with NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews were conducted with patients with NAFLD. Reflexive thematic analysis and framework analysis were used to determine naturally identified themes and allocate them to theoretically driven domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty adult patients with NAFLD were interviewed, and the identified themes were mapped directly onto the constructs of the HAPA model. This study revealed that key barriers to adhering to lifestyle prescriptions are related to the coping strategy and outcome expectation constructs of the HAPA model. For physical activity, conditional limits, lack of time, symptoms such as fatigue and poor physical fitness, and fear of sports injury are the primary barriers. Barriers to diet are mainly diet environment, mental stress, and food cravings. Key facilitators for adherence to lifestyle prescriptions include developing simple and specific action plans, coping strategies to flexibly deal with obstacles and difficulties, receiving regular feedback from doctors to improve self-efficacy, and using regular tests and behavior recording to enhance action control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Future lifestyle intervention programs should pay particular attention to the planning, self-efficacy, and action control-related constructors of the HAPA model to promote the adherence of patients with NAFLD to lifestyle prescriptions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2023.1131827","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T01:12:43Z","timestamp":1679015563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors influencing adherence to lifestyle prescriptions among patients with nonalcoholic fatty liver disease: A qualitative study using the health action process approach framework"],"prefix":"10.3389","volume":"11","author":[{"given":"Lina","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American association for the study of liver diseases (Aasld)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.07.045","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Easl-Easd-Easo clinical practice guidelines for the management of nonalcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1751-2980.12685","article-title":"Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)","volume":"20","author":"Fan","year":"2019","journal-title":"J Dig Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12325-018-0856-0","article-title":"Understanding patient preferences and unmet needs in nonalcoholic steatohepatitis (Nash): insights from a qualitative online bulletin board study","volume":"36","author":"Cook","year":"2019","journal-title":"Adv Ther."},{"key":"B8","article-title":"Tracy","volume-title":"Health Behavior and Health Education 4","author":"Glanz","year":"2008"},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15517\/ap.v30i121.23458","article-title":"Health action process approach (Hapa) as a theoretical framework to understand behavior change","volume":"30","author":"Schwarzer","year":"2016","journal-title":"Actualidades en Psicolog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1464-0597.2007.00325.x","article-title":"Modeling health behavior change: how to predict and modify the adoption and maintenance of health behaviors","volume":"57","author":"Schwarzer","year":"2008","journal-title":"Appl Psychol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"739100","DOI":"10.3389\/fpubh.2022.739100","article-title":"Wechat mini program-based intervention for physical activity, fruit and vegetable consumption among chinese cardiovascular patients in home-based rehabilitation: a study protocol","volume":"10","author":"Duan","year":"2022","journal-title":"Front Public Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.3390\/ijerph18105206","article-title":"Promoting fruit and vegetable intake in parents: a cluster randomised controlled trial","volume":"18","author":"Sun","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/08870446.2021.1900574","article-title":"A combined health action process approach and mhealth intervention to reduce sedentary behaviour in university students - a randomized controlled trial","volume":"37","author":"Dillon","year":"2022","journal-title":"Psychol Health."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10067-020-05224-y","article-title":"A theory-based intervention to promote medication adherence in patients with rheumatoid arthritis: a randomized controlled trial","volume":"40","author":"Asgari","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1037\/a0024509","article-title":"Mechanisms of health behavior change in persons with chronic illness or disability: the health action process approach (Hapa)","volume":"56","author":"Schwarzer","year":"2011","journal-title":"Rehabil Psychol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.sapharm.2014.11.010","article-title":"A framework for pharmacist-assisted medication adherence in hard-to-reach patients","volume":"11","author":"Wiener","year":"2015","journal-title":"Res Social Adm Pharm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health."},{"key":"B18","volume-title":"Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. 4th ed.","author":"Creswel","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","year":"2019","journal-title":"Qual Res Sport Exerc Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","article-title":"Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study","volume":"10","author":"Hallsworth","year":"2020","journal-title":"Transl Behav Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hex.13665","article-title":"Barriers and enabling factors in weight management of patients with nonalcoholic fatty liver disease: a qualitative study using the COM-B model of behaviour","volume":"26","author":"Gu","year":"2022","journal-title":"Health Expect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/jan.14340","article-title":"Factors influencing health behaviour, blood pressure control, and disability in hypertensive ischaemic stroke patients after a comprehensive reminder intervention","volume":"76","author":"Zhang","year":"2020","journal-title":"J Adv Nurs."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0127382","DOI":"10.1371\/journal.pone.0127382","article-title":"Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the Elsa-Brasil study","volume":"10","author":"Chor","year":"2015","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000282089","article-title":"Systemic symptoms in nonalcoholic fatty liver disease","volume":"28","author":"Newton","year":"2010","journal-title":"Dig Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.dsx.2021.05.011","article-title":"Perceived barriers and facilitators for adherence to lifestyle prescription: perspective of obese patients with non alcoholic fatty liver disease from North India","volume":"15","author":"Arora","year":"2021","journal-title":"Diabetes Metab Syndr."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192114215","article-title":"The relationship between health-related fitness and quality of life in nonalcoholic fatty liver disease","author":"Wang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pmrj.2015.06.001","article-title":"Perception of effort during activity in patients with chronic hepatitis C and nonalcoholic fatty liver disease","volume":"8","author":"Weinstein","year":"2016","journal-title":"PM R."},{"key":"B28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1464-5491.2009.02873.x","article-title":"Understanding physical activity facilitators and barriers during and following a supervised exercise programme in type 2 diabetes: a qualitative study","volume":"27","author":"Casey","year":"2010","journal-title":"Diabet Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.jhepr.2021.100322","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep."},{"key":"B30","volume-title":"Acsm's Exercise Testing and Prescription","author":"Medicine","year":"2017"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.cgh.2017.06.011","article-title":"Lifestyle behavior change in patients with nonalcoholic fatty liver disease: a qualitative study of clinical practice","volume":"15","author":"Avery","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000282101","article-title":"The effect of lifestyle changes in nonalcoholic fatty liver disease","volume":"28","author":"Centis","year":"2010","journal-title":"Dig Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e000634","DOI":"10.1136\/bmjgast-2021-000634","article-title":"Patient disease knowledge, attitudes and behaviours related to nonalcoholic fatty liver disease: a qualitative study","volume":"8","author":"Tincopa","year":"2021","journal-title":"BMJ Open Gastroenterol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1131827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T01:12:47Z","timestamp":1679015567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1131827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2023.1131827"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1131827","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1131827"}}